Find a Tender
complete
Official procurement procedure
NP34925c Anti Rabies immunoglobulin intramuscular use (IM)
Pharmaceutical products
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS): "NP34925c Anti Rabies immunoglobulin intramuscular use (IM)". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
Not availableNo published reports
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 0 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published2 May 2025, 13:33 BST | Last source update2 May 2025, 13:33 BST | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area | ||
OCIDocds-h6vhtk-050297 | ||
What is being bought
Supply of Anti Rabies immunoglobulin intramuscular use (IM) to NHS Scotland.
What changed
From the official release history
- Official notice release published
2 May 2025, 13:33 BST - Status changed to complete
14 Apr 2025, 14:31 BST - Official notice release published
14 Apr 2025, 14:31 BST - Buyer information updated
14 Apr 2025, 14:31 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedThe Framework Agreement is for the supply of Anti Rabies immunoglobulin intramuscular use (IM) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
2 May 2025, 13:33 BST - Award active
Not published · Not published - Contract active
Signed 30 Apr 2025, 00:00 BST · £544,320
Commercial outcome and competition
Awards Bio Products Laboratory Not published · Not published · active |
Contracts Contract £544,320 · signed 30 Apr 2025, 00:00 BST · active |
Bid statistics bids: 1 (lot 1) electronicBids: 1 (lot 1) foreignBidsFromEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) smeBids: 0 (lot 1) |
Buyer and organisations in this procedure
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Contracting authority GB-FTS-115937Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleAlthough Anti Rabies immunoglobulin intramuscular use (IM) has lost patent protection there is no known generic competition in the UK marketplace due to the difficulties in replicating the manufacturing process, in line with Regulation 33(1)(b)(ii) of the Public Contracts (Scotland) Regulations 2015. |